Bor‐Ru Lin

Phase I clinical trial of curcumin, a chemopreventive agent, in patients with high-risk or pre-malignant lesions.

Ann‐Lii Cheng, Chih‐Hung Hsu, Jen‐Kou Lin et al. · PubMed · 2001 · 2.1K citations

Medicine, Oncology, Pharmacology +10

High-dose Dual Therapy Is Superior to Standard First-line or Rescue Therapy for Helicobacter pylori Infection

Jyh‐Chin Yang, Chun‐Jung Lin, Hong-Long Wang et al. · Clinical Gastroenterology and Hepatology · 2014 · 198 citations · Full text

Pharmacy, Infectious Diseases, Pharmacotherapy +5

The Induction of Prostaglandin E2 Production, Interleukin-6 Production, Cell Cycle Arrest, and Cytotoxicity in Primary Oral Keratinocytes and KB Cancer Cells by Areca Nut Ingredients Is Differentially Regulated by MEK/ERK Activation

Mei‐Chi Chang, Hui‐Lin Wu, Jang‐Jaer Lee et al. · Journal of Biological Chemistry · 2004 · 128 citations · Full text

Medicine, Cancer Biology, Oncology +15

Effects of areca nut, inflorescence <i>piper betle</i> extracts and arecoline on cytotoxicity, total and unscheduled DNA synthesis in cultured gingival keratinocytes

Jiiang‐Huei Jeng, Liang‐Jiunn Hahn, Bor‐Ru Lin et al. · Journal of Oral Pathology and Medicine · 1999 · 107 citations

Dentistry, Oral Biology, Oral Medicine +14

Induction of necrosis and apoptosis to KB cancer cells by sanguinarine is associated with reactive oxygen species production and mitochondrial membrane depolarization

Mei‐Chi Chang, Chiu‐Po Chan, Ying‐Jan Wang et al. · Toxicology and Applied Pharmacology · 2006 · 86 citations

Life Sciences, Cell Biology, Oncology +16